Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Customer Service

Request Literature

Request literature from Sigma-Aldrich

Newsletters

Subscribe to free eNews and other newsletters from Sigma-Aldrich

Base Invaders Game

Visit Max's laboratory to amplify as many DNA fragments as possible to generate the correct base pairs

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

St. Louis, MO - July 29, 2014 Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives

New Report Shows Positive Impacts of Company's Global Citizenship Efforts

Sigma-Aldrich Corporation (NASDAQ: SIAL) dramatically decreased its global water and energy use, increased its investment in Green Chemistry and donated more than 8,000 hours of community service around the world last year, the Company announced Monday in its new 2013 Global Citizenship Report: What if Science Changed the World?

Read More
St. Louis, MO - June 30, 2014 Sigma-Aldrich CFO Jan Bertsch Named One of St. Louis’ Most Influential Business Women

Sigma-Aldrich Corporation (NASDAQ: SIAL) is proud to announce that Executive Vice President and Chief Financial Officer Jan Bertsch has been named one of St. Louis’ Most Influential Business Women by the St. Louis Business Journal.

Read More
St. Louis, MO - June 24, 2014 AGTC and SAFC Create Strategic Partnership to Provide Gene Therapy Manufacturing Services

Applied Genetic Technologies Corporation (NASDAQ: AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, and SAFC Commercial (SAFC), the Sigma-Aldrich Corporation (NASDAQ: SIAL) business unit that manufactures specialty chemicals and biologics for commercial life science applications, today announced that they signed an agreement to have SAFC provide gene therapy manufacturing services to companies developing gene-based therapies.

Read More
St. Louis, MO - May 20, 2014 SAFC Expands Continuous Flow Capabilities for Research and Commercial Scale

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial, its custom manufacturing services business unit, has installed a new commercial-scale continuous flow reactor at its Sheboygan, Wis., facility with  capacity to produce up to 150 kg of product per day.

Read More